Pharmaceutical care unit guideline implementation

The effect of obligation for using indication checklist based on guidelines on the amount of costly medication usage in the hospital setting

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT20161010030246N2

Enrollment

10000

Registered

2018-07-13

Start date

2015-06-22

Completion date

Unknown

Last updated

2018-09-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Clinical condition or disease that need treatment with albumin, IV pantoprazole, or IVIG. Persons encountering health services for specific procedures and health care

Interventions

Intervention group: Designing the indication checklist for studied medications that should be examined by the pharmacy team based on clinical and paraclinical data of patients.

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Receiving albumin, IV pantoprazole, or intravenous immuneglobulin

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Total consumption and direct medication cost. Timepoint: 6 months before and after the intervention. Method of measurement: Hospital Information System.	—

Secondary

Measure	Time frame
All-cause in-hospital mortality and hospital length of stay. Timepoint: 6 months before and after the intervention. Method of measurement: Hospital Information System.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactIman Karimzadeh

Shiraz University of Medical Sciences

karimzadee@sums.ac.ir+98 71 3647 4332

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026